chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Rash, Tremor
Clinical narrative: Sense of taste lost; Blurry vision; Fever; Shaking; I couldn't get warm enough; Nausea; I threw up; Hurt all over; My bones hurt; I was tired; Headache; rash; This spontaneous case was reported by a pharmacist and describes the occurrence of AGEUSIA (Sense of taste lost), VISION BLURRED (Blurry vision), PYREXIA (Fever), TREMOR (Shaking) and FEELING COLD (I couldn't get warm enough) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seizures and Migraine. Concomitant products included RIZATRIPTAN BENZOATE (MAXALT) for Migraine, ESLICARBAZEPINE ACETATE (APTIOM) for Seizure, PANTOPRAZOLE SODIUM SESQUIHYDRATE (PANTOPRAZOLE 40), TIZANIDINE and FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AGEUSIA (Sense of taste lost), VISION BLURRED (Blurry vision), PYREXIA (Fever), TREMOR (Shaking), FEELING COLD (I couldn't get warm enough), NAUSEA (Nausea), VOMITING (I threw up), PAIN (Hurt all over), BONE PAIN (My bones hurt), FATIGUE (I was tired), HEADACHE (Headache) and RASH (rash). At the time of the report, AGEUSIA (Sense of taste lost), VISION BLURRED (Blurry vision), PYREXIA (Fever), TREMOR (Shaking), FEELING COLD (I couldn't get warm enough), NAUSEA (Nausea), VOMITING (I threw up), PAIN (Hurt all over) and BONE PAIN (My bones hurt) had resolved and FATIGUE (I was tired), HEADACHE (Headache) and RASH (rash) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 15-Feb-2021: No specific follow-up information recorded.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, Vomiting
Clinical narrative: Sense of taste lost; Blurry vision; Fever; Shaking; I couldn't get warm enough; Nausea; I threw up; Hurt all over; My bones hurt; I was tired; Headache; rash; This spontaneous case was reported by a pharmacist and describes the occurrence of AGEUSIA (Sense of taste lost), VISION BLURRED (Blurry vision), PYREXIA (Fever), TREMOR (Shaking) and FEELING COLD (I couldn't get warm enough) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seizures and Migraine. Concomitant products included RIZATRIPTAN BENZOATE (MAXALT) for Migraine, ESLICARBAZEPINE ACETATE (APTIOM) for Seizure, PANTOPRAZOLE SODIUM SESQUIHYDRATE (PANTOPRAZOLE 40), TIZANIDINE and FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AGEUSIA (Sense of taste lost), VISION BLURRED (Blurry vision), PYREXIA (Fever), TREMOR (Shaking), FEELING COLD (I couldn't get warm enough), NAUSEA (Nausea), VOMITING (I threw up), PAIN (Hurt all over), BONE PAIN (My bones hurt), FATIGUE (I was tired), HEADACHE (Headache) and RASH (rash). At the time of the report, AGEUSIA (Sense of taste lost), VISION BLURRED (Blurry vision), PYREXIA (Fever), TREMOR (Shaking), FEELING COLD (I couldn't get warm enough), NAUSEA (Nausea), VOMITING (I threw up), PAIN (Hurt all over) and BONE PAIN (My bones hurt) had resolved and FATIGUE (I was tired), HEADACHE (Headache) and RASH (rash) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 15-Feb-2021: No specific follow-up information recorded.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous
Clinical narrative: Itchy upper limbs; Red rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy upper limbs) and RASH ERYTHEMATOUS (Red rash) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PRURITUS (Itchy upper limbs) and RASH ERYTHEMATOUS (Red rash). At the time of the report, PRURITUS (Itchy upper limbs) and RASH ERYTHEMATOUS (Red rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vision blurred
Clinical narrative: Blurry vision; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision) and NAUSEA (Nauseous) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VISION BLURRED (Blurry vision) and NAUSEA (Nauseous). On 13-Feb-2021, VISION BLURRED (Blurry vision) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Injection site injury
Clinical narrative: Wound at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INJURY (Wound at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE INJURY (Wound at injection site). At the time of the report, INJECTION SITE INJURY (Wound at injection site) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Right face going numb; Tingling; Numbness in her left arm, through her left breast and armpits.; through her left breast and armpits; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 041L70A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced PARAESTHESIA (Tingling). On 13-Feb-2021, PARAESTHESIA (Tingling) had resolved.            This case was linked to MOD-2021-015162, MOD-2021-041709, MOD-2021-015162 (Patient Link).
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Cough; Fever; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), COVID-19 (COVID-19) and PYREXIA (Fever) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included IRBESARTAN and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced COUGH (Cough) and PYREXIA (Fever). At the time of the report, COUGH (Cough), COVID-19 (COVID-19) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Myalgia, Taste disorder
Clinical narrative: chills; funny taste in mouth; body aches; flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), TASTE DISORDER (funny taste in mouth), MYALGIA (body aches) and INFLUENZA LIKE ILLNESS (flu-like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), TASTE DISORDER (funny taste in mouth), MYALGIA (body aches) and INFLUENZA LIKE ILLNESS (flu-like symptoms). At the time of the report, CHILLS (chills), TASTE DISORDER (funny taste in mouth), MYALGIA (body aches) and INFLUENZA LIKE ILLNESS (flu-like symptoms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chills, Dizziness, Headache, Hyperhidrosis
Clinical narrative: FEVER; sweating; CHILLS; RASH; HEADACHE; Dizzy; Red rash all over neck and chest; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), RASH ERYTHEMATOUS (Red rash all over neck and chest), CHILLS (CHILLS), HEADACHE (HEADACHE) and PYREXIA (FEVER) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history reported).   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Dec-2020, the patient experienced DIZZINESS (Dizzy) and RASH ERYTHEMATOUS (Red rash all over neck and chest). On 01-Jan-2021, the patient experienced HEADACHE (HEADACHE). On 28-Jan-2021, the patient experienced RASH (RASH). On 29-Jan-2021, the patient experienced CHILLS (CHILLS). On an unknown date, the patient experienced PYREXIA (FEVER) and HYPERHIDROSIS ( sweating ). At the time of the report, DIZZINESS (Dizzy), CHILLS (CHILLS), HEADACHE (HEADACHE) and HYPERHIDROSIS ( sweating ) had not resolved and RASH ERYTHEMATOUS (Red rash all over neck and chest), PYREXIA (FEVER) and RASH (RASH) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement (120/80-161/71 mmHg): 161/71 mmHg 161/71.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Rash erythematous
Clinical narrative: FEVER; sweating; CHILLS; RASH; HEADACHE; Dizzy; Red rash all over neck and chest; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), RASH ERYTHEMATOUS (Red rash all over neck and chest), CHILLS (CHILLS), HEADACHE (HEADACHE) and PYREXIA (FEVER) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history reported).   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Dec-2020, the patient experienced DIZZINESS (Dizzy) and RASH ERYTHEMATOUS (Red rash all over neck and chest). On 01-Jan-2021, the patient experienced HEADACHE (HEADACHE). On 28-Jan-2021, the patient experienced RASH (RASH). On 29-Jan-2021, the patient experienced CHILLS (CHILLS). On an unknown date, the patient experienced PYREXIA (FEVER) and HYPERHIDROSIS ( sweating ). At the time of the report, DIZZINESS (Dizzy), CHILLS (CHILLS), HEADACHE (HEADACHE) and HYPERHIDROSIS ( sweating ) had not resolved and RASH ERYTHEMATOUS (Red rash all over neck and chest), PYREXIA (FEVER) and RASH (RASH) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement (120/80-161/71 mmHg): 161/71 mmHg 161/71.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Injection site rash, Nausea
Clinical narrative: injection site soreness; injection site rash; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (injection site soreness), INJECTION SITE RASH (injection site rash) and NAUSEA (Nausea) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (medical history was not provided).    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced INJECTION SITE PAIN (injection site soreness) and INJECTION SITE RASH (injection site rash). 12-Feb-2021, the patient experienced NAUSEA (Nausea). At the time of the report, INJECTION SITE PAIN (injection site soreness), INJECTION SITE RASH (injection site rash) and NAUSEA (Nausea) outcome was unknown.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Pain in extremity, Vomiting
Clinical narrative: Sore arm; Diarrhea; Had massive vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), DIARRHOEA (Diarrhea) and VOMITING (Had massive vomiting) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history was reported.). Concomitant products included FUROSEMIDE (LASIX [FUROSEMIDE]), VITAMIN B1 NOS, VITAMIN B12 [VITAMIN B12 NOS], VITAMIN C [ASCORBIC ACID], VITAMIN D3, CALCIUM, COLECALCIFEROL (CALCIUM PLUS D3), PREGABALIN (LYRICA), ALLOPURINOL, TIOTROPIUM BROMIDE (SPIRIVA), FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (WIXELA INHUB), FINASTERIDE, APIXABAN (ELIQUIS), AZELASTINE, ATORVASTATIN, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), DILTIAZEM, DOCUSATE SODIUM (COLACE), MONTELUKAST, CLINDAMYCIN and GLYCERYL TRINITRATE (NITROSTAT) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), DIARRHOEA (Diarrhea) and VOMITING (Had massive vomiting). At the time of the report, PAIN IN EXTREMITY (Sore arm), DIARRHOEA (Diarrhea) and VOMITING (Had massive vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia, Pyrexia
Clinical narrative: Myalgia; Mobility decreased; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Myalgia), MOBILITY DECREASED (Mobility decreased) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced MYALGIA (Myalgia), MOBILITY DECREASED (Mobility decreased) and PYREXIA (fever). At the time of the report, MYALGIA (Myalgia), MOBILITY DECREASED (Mobility decreased) and PYREXIA (fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 35-year-old female patient (gravida 4) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Miscarriage in August 2018, Graves' disease in March 2020 and Alcohol use (2glasses of wine every month.) in July 2020. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Breast feeding.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in July 2020 and the estimated date of delivery was 12-Apr-2021. On 17-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 17-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Aug-2020, Pregnancy: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment was not provided.  Estimated date of conception was reported in Jul-2020. Number of previous pregnancies reported were 3 from which one resulted as spontaneous abortion via miscarriage in Aug-2018.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Headaches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) and FATIGUE (Fatigue) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy and Allergy.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced HEADACHE (Headaches) and FATIGUE (Fatigue). On 12-Jan-2021, HEADACHE (Headaches) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reactions) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION COMPLICATION (Reactions). At the time of the report, VACCINATION COMPLICATION (Reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypotension
Clinical narrative: Blood pressure was way down; A spontaneous report was received from a (Reporter like HCP or Consumer) concerning a  Years-old male/female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event list his BP was 119/87, 116/79 - below normal reading.  The patient's medical history was not provided. relevant concomitant vitamin C 100mg multivitamin for eyes plavix 75mg Voltaren gel 1% Toprol xl 50mg twice daily doxycycline 100mg Vit D 2 once a week acetaminophen 500mg prn 2-3 in a day imipramine 50mg   On Date or unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 031M20A )   Laboratory details  was not  provided.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   On 14-feb-2021, The outcome of event is recovered and resolved.  The reporter assessed the event BP was 119/87, 116/79 - below normal readings related to study drug.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Injection site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Vaccination site warmth; vaccination site pruritus; Injection site erythema; This spontaneous case was reported by a consumer and describes the occurrence of   in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL / HCT CENTRAFARM) for Blood pressure high, METOPROLOL SUCCINATE (METOPROLOL [METOPROLOL SUCCINATE]) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-091924 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Non-Significant follow up appended to AER
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Nausea, Vaccination site lymphadenopathy
Clinical narrative: Headache; lymph nodes in neck swollen on left side; Brightness in vision; chills; Nausea; sorenes in arm; This spontaneous case was reported by a patient and describes the occurrence of VISUAL BRIGHTNESS (Brightness in vision), CHILLS (chills), HEADACHE (Headache), NAUSEA (Nausea) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in neck swollen on left side) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No relevant medical history provided).    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced CHILLS (chills), NAUSEA (Nausea) and INJECTION SITE PAIN (sorenes in arm). On 15-Feb-2021, the patient experienced VISUAL BRIGHTNESS (Brightness in vision). On 16-Feb-2021, the patient experienced HEADACHE (Headache) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in neck swollen on left side). At the time of the report, VISUAL BRIGHTNESS (Brightness in vision), CHILLS (chills), HEADACHE (Headache), NAUSEA (Nausea), VACCINATION SITE LYMPHADENOPATHY (lymph nodes in neck swollen on left side) and INJECTION SITE PAIN (sorenes in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Visual brightness
Clinical narrative: Headache; lymph nodes in neck swollen on left side; Brightness in vision; chills; Nausea; sorenes in arm; This spontaneous case was reported by a patient and describes the occurrence of VISUAL BRIGHTNESS (Brightness in vision), CHILLS (chills), HEADACHE (Headache), NAUSEA (Nausea) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in neck swollen on left side) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No relevant medical history provided).    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced CHILLS (chills), NAUSEA (Nausea) and INJECTION SITE PAIN (sorenes in arm). On 15-Feb-2021, the patient experienced VISUAL BRIGHTNESS (Brightness in vision). On 16-Feb-2021, the patient experienced HEADACHE (Headache) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in neck swollen on left side). At the time of the report, VISUAL BRIGHTNESS (Brightness in vision), CHILLS (chills), HEADACHE (Headache), NAUSEA (Nausea), VACCINATION SITE LYMPHADENOPATHY (lymph nodes in neck swollen on left side) and INJECTION SITE PAIN (sorenes in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Mass, Pain in extremity, Vaccination site erythema, Vaccination site induration
Clinical narrative: Blister like bumps; Arm Sore; Injection site pink/redness; Injection site induration; Delayed injection site reaction; Injection site swollen; Injection site warm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE REACTION (Delayed injection site reaction), PAIN IN EXTREMITY (Arm Sore), VACCINATION SITE WARMTH (Injection site warm), MASS (Blister like bumps) and VACCINATION SITE INDURATION (Injection site induration) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced PAIN IN EXTREMITY (Arm Sore). On 06-Jan-2021, the patient experienced VACCINATION SITE REACTION (Delayed injection site reaction), VACCINATION SITE ERYTHEMA (Injection site pink/redness) and VACCINATION SITE SWELLING (Injection site swollen). On 07-Jan-2021, the patient experienced MASS (Blister like bumps). On 08-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Injection site warm). In January 2021, the patient experienced VACCINATION SITE INDURATION (Injection site induration). On 29-Dec-2020, PAIN IN EXTREMITY (Arm Sore) had resolved. At the time of the report, VACCINATION SITE REACTION (Delayed injection site reaction), VACCINATION SITE WARMTH (Injection site warm), MASS (Blister like bumps), VACCINATION SITE INDURATION (Injection site induration), VACCINATION SITE ERYTHEMA (Injection site pink/redness) and VACCINATION SITE SWELLING (Injection site swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Body temperature: 99.3 Temp 99.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Blister like bumps; Arm Sore; Injection site pink/redness; Injection site induration; Delayed injection site reaction; Injection site swollen; Injection site warm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE REACTION (Delayed injection site reaction), PAIN IN EXTREMITY (Arm Sore), VACCINATION SITE WARMTH (Injection site warm), MASS (Blister like bumps) and VACCINATION SITE INDURATION (Injection site induration) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced PAIN IN EXTREMITY (Arm Sore). On 06-Jan-2021, the patient experienced VACCINATION SITE REACTION (Delayed injection site reaction), VACCINATION SITE ERYTHEMA (Injection site pink/redness) and VACCINATION SITE SWELLING (Injection site swollen). On 07-Jan-2021, the patient experienced MASS (Blister like bumps). On 08-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Injection site warm). In January 2021, the patient experienced VACCINATION SITE INDURATION (Injection site induration). On 29-Dec-2020, PAIN IN EXTREMITY (Arm Sore) had resolved. At the time of the report, VACCINATION SITE REACTION (Delayed injection site reaction), VACCINATION SITE WARMTH (Injection site warm), MASS (Blister like bumps), VACCINATION SITE INDURATION (Injection site induration), VACCINATION SITE ERYTHEMA (Injection site pink/redness) and VACCINATION SITE SWELLING (Injection site swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Body temperature: 99.3 Temp 99.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Tendonitis
Clinical narrative: tenitis worsen; This spontaneous case was reported by a consumer and describes the occurrence of TENDONITIS (tenitis worsen) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TENDONITIS (tenitis worsen). At the time of the report, TENDONITIS (tenitis worsen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment details not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Skin irritation, Vaccination site swelling, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (having some irritated skin, heating and swelling at the injection site.), VACCINATION SITE WARMTH (heating at the injection site) and VACCINATION SITE SWELLING (having some irritated skin, heating and swelling at the injection site.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced SKIN IRRITATION (having some irritated skin, heating and swelling at the injection site.), VACCINATION SITE WARMTH (heating at the injection site) and VACCINATION SITE SWELLING (having some irritated skin, heating and swelling at the injection site.). The patient was treated with CELECOXIB (CORTAX [CELECOXIB]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SKIN IRRITATION (having some irritated skin, heating and swelling at the injection site.), VACCINATION SITE WARMTH (heating at the injection site) and VACCINATION SITE SWELLING (having some irritated skin, heating and swelling at the injection site.) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment included cold compresses.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity
Clinical narrative: swollen lymph nodes on the left side, including above her clavicle; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and LYMPHADENOPATHY (swollen lymph nodes on the left side, including above her clavicle) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 15-Feb-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes on the left side, including above her clavicle). At the time of the report, PAIN IN EXTREMITY (Sore arm) and LYMPHADENOPATHY (swollen lymph nodes on the left side, including above her clavicle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site). On 11-Feb-2021, VACCINATION SITE PAIN (Pain at injection site) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment medication was not reported by the reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Chills; headache; extreme body aches; joint pain; severe fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (headache), MYALGIA (extreme body aches), ARTHRALGIA (joint pain) and FATIGUE (severe fatigue) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced CHILLS (Chills), HEADACHE (headache), MYALGIA (extreme body aches), ARTHRALGIA (joint pain) and FATIGUE (severe fatigue). At the time of the report, CHILLS (Chills), HEADACHE (headache), MYALGIA (extreme body aches), ARTHRALGIA (joint pain) and FATIGUE (severe fatigue) outcome was unknown.            Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: can hardly lift her arm; red rash, tenderness and itchiness at the injection site; red rash, tenderness and itchiness at the injection site; red rash, tenderness and itchiness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (can hardly lift her arm), VACCINATION SITE PAIN (red rash, tenderness and itchiness at the injection site), VACCINATION SITE RASH (red rash, tenderness and itchiness at the injection site) and VACCINATION SITE PRURITUS (red rash, tenderness and itchiness at the injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (red rash, tenderness and itchiness at the injection site), VACCINATION SITE RASH (red rash, tenderness and itchiness at the injection site) and VACCINATION SITE PRURITUS (red rash, tenderness and itchiness at the injection site). On 17-Feb-2021, the patient experienced MUSCULAR WEAKNESS (can hardly lift her arm). At the time of the report, MUSCULAR WEAKNESS (can hardly lift her arm), VACCINATION SITE PAIN (red rash, tenderness and itchiness at the injection site), VACCINATION SITE RASH (red rash, tenderness and itchiness at the injection site) and VACCINATION SITE PRURITUS (red rash, tenderness and itchiness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Eye irritation, Ocular hyperaemia
Clinical narrative: Allergic reaction to the vaccine; right eye became red; right eye became irritated; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ALLERGY TO VACCINE (Allergic reaction to the vaccine), OCULAR HYPERAEMIA (right eye became red) and EYE IRRITATION (right eye became irritated) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (Allergic reaction to the vaccine), OCULAR HYPERAEMIA (right eye became red) and EYE IRRITATION (right eye became irritated). At the time of the report, ALLERGY TO VACCINE (Allergic reaction to the vaccine), OCULAR HYPERAEMIA (right eye became red) and EYE IRRITATION (right eye became irritated) outcome was unknown.            Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia, Somnolence
Clinical narrative: Fever; fatigue; Sleepy; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), FATIGUE (fatigue), SOMNOLENCE (Sleepy) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PYREXIA (Fever), FATIGUE (fatigue), SOMNOLENCE (Sleepy) and CHILLS (chills). At the time of the report, PYREXIA (Fever), FATIGUE (fatigue), SOMNOLENCE (Sleepy) and CHILLS (chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Eye movement disorder
Clinical narrative: felt really really dizzy; eyes roll to the back of my head; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt really really dizzy) and EYE MOVEMENT DISORDER (eyes roll to the back of my head) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced DIZZINESS (felt really really dizzy) and EYE MOVEMENT DISORDER (eyes roll to the back of my head). At the time of the report, DIZZINESS (felt really really dizzy) and EYE MOVEMENT DISORDER (eyes roll to the back of my head) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: slight pink blotch 2 inches down and an inch over the vaccination site; itchy; felt like a knot; tenderness over vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (slight pink blotch 2 inches down and an inch over the vaccination site), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE INDURATION (felt like a knot) and VACCINATION SITE PAIN (tenderness over vaccination site) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced RASH MACULAR (slight pink blotch 2 inches down and an inch over the vaccination site), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE INDURATION (felt like a knot) and VACCINATION SITE PAIN (tenderness over vaccination site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form and CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) at a dose of 1 dosage form. On 16-Feb-2021, RASH MACULAR (slight pink blotch 2 inches down and an inch over the vaccination site) outcome was unknown and VACCINATION SITE PRURITUS (itchy), VACCINATION SITE INDURATION (felt like a knot) and VACCINATION SITE PAIN (tenderness over vaccination site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment details provided as Benadryl tablets and calamine lotion.   This case was linked to MOD-2021-021171 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: follow up received on 24-06-21 with NNI
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: pink, burned like peeled skin at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (pink, burned like peeled skin at the injection site) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (pink, burned like peeled skin at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (pink, burned like peeled skin at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: vaccination site pruritis; vaccination site redness; vaccination site swelling; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (sore arm), VACCINATION SITE PRURITUS (vaccination site pruritis), VACCINATION SITE ERYTHEMA (vaccination site redness) and VACCINATION SITE SWELLING (vaccination site swelling) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced ARTHRALGIA (sore arm). On 16-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (vaccination site pruritis), VACCINATION SITE ERYTHEMA (vaccination site redness) and VACCINATION SITE SWELLING (vaccination site swelling). On 10-Feb-2021, ARTHRALGIA (sore arm) had resolved. At the time of the report, VACCINATION SITE PRURITUS (vaccination site pruritis), VACCINATION SITE ERYTHEMA (vaccination site redness) and VACCINATION SITE SWELLING (vaccination site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.